Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Deerfield Management Company, L.P. | 17.25M | $2.13B | 21.92% | -- | 2026-06-30 |
| Paradigm Biocapital Advisors LP | 5.92M | $731.0M | 7.53% | +600.0K | 2026-06-30 |
| BlackRock, Inc. | 5.59M | $689.0M | 7.10% | +760.8K | 2026-06-30 |
| Hbk Investments L P | 3.48M | $430.0M | 4.43% | -- | 2026-06-30 |
| FIL Ltd | 2.95M | $363.0M | 3.75% | +2.95M | 2026-06-30 |
| Vanguard Portfolio Management LLC | 2.59M | $319.0M | 3.29% | +88.4K | 2026-06-30 |
| Vanguard Capital Management LLC | 2.46M | $303.0M | 3.13% | +30.6K | 2026-06-30 |
| State Street Corp | 2.09M | $258.0M | 2.66% | +55.2K | 2026-06-30 |
| Deep Track Capital, LP | 1.78M | $220.0M | 2.27% | +407.0K | 2026-06-30 |
| Glazer Capital, LLC | 1.77M | $218.0M | 2.25% | -- | 2026-06-30 |
